SecSonar.com

IRadimed Corporation (IRMD)

IRadimed Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

IRadimed Corporation (IRMD) is a Medical - Devices company based in US with a market capitalization of $1.2B. Revenue grew 14.4% year-over-year and the company generated $17.2M in free cash flow. This page tracks IRMD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 160 employees · IPO Jul 16, 2014

Valuation

Valuation & price

$86.44 · as of May 17, 2026 · -17.8% vs 52w high

49.4

P/E ratio

Latest-FY diluted EPS

12.65

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$104$80.24$56.19Jul 25Dec 25Jun 26Jul 7, 25$59.02Jul 9, 25$59.82Jul 11, 25$57.57Jul 15, 25$57.83Jul 17, 25$57.45Jul 21, 25$56.19Jul 23, 25$57.00Jul 25, 25$56.32Jul 29, 25$57.80Jul 31, 25$58.34Aug 4, 25$70.69Aug 6, 25$70.32Aug 8, 25$69.93Aug 12, 25$73.00Aug 14, 25$70.15Aug 19, 25$70.00Aug 21, 25$70.53Aug 25, 25$71.50Aug 27, 25$73.85Aug 29, 25$72.44Sep 3, 25$70.60Sep 5, 25$71.99Sep 9, 25$71.89Sep 11, 25$74.27Sep 15, 25$71.61Sep 17, 25$70.76Sep 19, 25$70.52Sep 23, 25$71.57Sep 25, 25$68.55Sep 29, 25$70.07Oct 2, 25$71.08Oct 6, 25$71.76Oct 8, 25$76.87Oct 10, 25$71.68Oct 14, 25$73.24Oct 16, 25$76.05Oct 20, 25$74.69Oct 22, 25$77.58Oct 24, 25$78.47Oct 28, 25$79.79Oct 30, 25$76.42Nov 3, 25$84.11Nov 5, 25$84.96Nov 7, 25$84.33Nov 11, 25$84.64Nov 14, 25$84.35Nov 18, 25$86.18Nov 20, 25$87.51Nov 24, 25$90.31Nov 26, 25$92.83Dec 1, 25$92.31Dec 3, 25$93.18Dec 5, 25$94.57Dec 9, 25$96.76Dec 11, 25$97.38Dec 15, 25$97.02Dec 17, 25$94.02Dec 19, 25$97.19Dec 23, 25$96.60Dec 26, 25$97.45Dec 31, 25$97.28Jan 5, 26$98.30Jan 7, 26$98.34Jan 9, 26$98.95Jan 13, 26$99.25Jan 15, 26$102.57Jan 20, 26$102.98Jan 22, 26$103.89Jan 26, 26$100.10Jan 28, 26$97.92Jan 30, 26$97.88Feb 3, 26$97.98Feb 5, 26$94.54Feb 9, 26$95.97Feb 11, 26$103.08Feb 17, 26$100.63Feb 19, 26$100.86Feb 23, 26$101.03Feb 25, 26$100.50Feb 27, 26$103.53Mar 3, 26$104.29Mar 5, 26$100.10Mar 9, 26$100.18Mar 11, 26$100.81Mar 13, 26$99.69Mar 17, 26$102.80Mar 19, 26$99.85Mar 23, 26$99.20Mar 25, 26$101.78Mar 27, 26$97.36Apr 1, 26$96.54Apr 6, 26$95.66Apr 8, 26$97.33Apr 10, 26$93.40Apr 14, 26$93.56Apr 16, 26$91.88Apr 20, 26$92.93Apr 22, 26$90.14Apr 24, 26$88.68Apr 28, 26$84.49Apr 30, 26$83.44May 4, 26$84.92May 6, 26$86.24May 8, 26$86.29May 12, 26$84.75May 15, 26$86.44May 19, 26$87.36May 21, 26$93.17May 26, 26$92.94May 28, 26$92.19Jun 1, 26$92.05Jun 3, 26$91.12Jun 5, 26$93.07Jun 9, 26$96.42Jun 11, 26$96.26Jun 15, 26$90.79Jun 17, 26$91.09Jun 22, 26$91.69Jun 24, 26$94.66Jun 30, 26$93.14
$56.1952-week range$105.15
Loading valuation history…

Fundamentals

Key fundamentals

$1.2B

Market cap

14.4%

Revenue growth (YoY)

76.8%

Gross margin

$17.2M

Free cash flow (USD)

-$51.2M

Net debt

Net cash position

0.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$32.5MFY 2017$23.1MFY 2018$30.4MFY 2019$38.5MFY 2020$31.7MFY 2021$41.8MFY 2022$53.3MFY 2023$65.6MFY 2024$73.2MFY 2025$83.8M
$32.5M$83.8M

Free cash flow by year

2016 → 2025

FY 2016$7.9MFY 2017$2.6MFY 2018$7.1MFY 2019$9.7MFY 2020$5.2MFY 2021$10.5MFY 2022$8.2MFY 2023$5.5MFY 2024$17.6MFY 2025$17.2M
$7.9M$17.2M

Gross margin by year

2021 → 2025

FY 202176.7%FY 202277.5%FY 202376.5%FY 202476.9%FY 202576.8%
76.7%76.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

10

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 24, 2026Filing
  • Insider sellInsider Sell $285KScharen-Guivel Hilda Frederique · Director · $285KJun 4, 2026Filing
  • Insider sellInsider Sell $227K · 10b5-1 PlanSusi Roger E. · Director, CEO, President, Chairman, 10% Owner · $226.5KJun 2, 2026Filing
  • Insider sellInsider Sell $691K · 10b5-1 PlanSusi Roger E. · Director, CEO, President, Chairman, 10% Owner · $691KMay 28, 2026Filing
  • Insider sellInsider Sell $657K · 10b5-1 PlanSusi Roger E. · Director, CEO, President, Chairman, 10% Owner · $657.3KMay 20, 2026Filing
  • Insider sellInsider Sell $631K · 10b5-1 PlanSusi Roger E. · Director, CEO, President, Chairman, 10% Owner · $631.3KMay 13, 2026Filing
  • Insider sellInsider Sell $643K · 10b5-1 PlanSusi Roger E. · Director, CEO, President, Chairman, 10% Owner · $642.9KMay 6, 2026Filing
  • 8-K eventEarnings Release and Dividend DeclaredMay 1, 2026Filing
  • Quarterly report10-Q FiledMay 1, 2026Filing
  • Insider sellInsider Sell $658K · 10b5-1 PlanSusi Roger E. · Director, CEO, President, Chairman, 10% Owner · $657.7KApr 30, 2026Filing

Questions

Frequently asked questions

What is IRadimed Corporation's market cap?

IRadimed Corporation (IRMD) has a market capitalization of $1.2B.

What is IRMD's P/E ratio?

IRMD trades at a price-to-earnings ratio of 49.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is IRMD's price-to-book (P/B) ratio?

IRMD trades at 12.65 times book value per share.

Are insiders buying IRMD stock?

SEC Form 4 filings show no open-market insider buys at IRadimed Corporation in the last 90 days (10 sells).

Same arena

Related companies in Medical - Devices

ATEC

Alphatec Holdings, Inc.

$1.2B

TNDM

Tandem Diabetes Care, Inc.

$1.2B

INSP

Inspire Medical Systems, Inc.

$1.2B

AVNS

Avanos Medical, Inc.

$1.2B

BFLY

Butterfly Network, Inc.

$1.2B

IART

Integra LifeSciences Holdings Corporation

$1.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.